Amneal Pharmaceuticals Launches First 2 Inhalers in US

MT Newswires Live04-14

Amneal Pharmaceuticals (AMRX) said Tuesday it launched albuterol sulfate and beclomethasone dipropionate inhalation products in the US, following their approval by the Food and Drug Administration in 2025.

The company said albuterol sulfate and beclomethasone dipropionate inhalation aerosol products are the generic versions of ProAir HFA and QVAR, respectively, and their launching marks the company's entry into the metered-dose inhaler category.

Both inhalers use a hand-breath actuator device, offering an option that had previously been discontinued for QVAR, potentially expanding patient choice, Amneal said.

Shares of the company were up more than 1% in premarket activity Tuesday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2627413414?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-14 21:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2627413414","market":"sh","top_or_hot":-1,"title":"Amneal Pharmaceuticals Launches First 2 Inhalers in US","media":"MT Newswires Live","content":"<html><body><p> Amneal Pharmaceuticals (AMRX) said Tuesday it launched albuterol sulfate and beclomethasone dipropionate inhalation products in the US, following their approval by the Food and Drug Administration in 2025.</p><p>The company said albuterol sulfate and beclomethasone dipropionate inhalation aerosol products are the generic versions of ProAir HFA and QVAR, respectively, and their launching marks the company's entry into the metered-dose inhaler category.</p><p>Both inhalers use a hand-breath actuator device, offering an option that had previously been discontinued for QVAR, potentially expanding patient choice, Amneal said.</p><p>Shares of the company were up more than 1% in premarket activity Tuesday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amneal Pharmaceuticals Launches First 2 Inhalers in US</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmneal Pharmaceuticals Launches First 2 Inhalers in US\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-04-14 21:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Amneal Pharmaceuticals (AMRX) said Tuesday it launched albuterol sulfate and beclomethasone dipropionate inhalation products in the US, following their approval by the Food and Drug Administration in 2025.</p><p>The company said albuterol sulfate and beclomethasone dipropionate inhalation aerosol products are the generic versions of ProAir HFA and QVAR, respectively, and their launching marks the company's entry into the metered-dose inhaler category.</p><p>Both inhalers use a hand-breath actuator device, offering an option that had previously been discontinued for QVAR, potentially expanding patient choice, Amneal said.</p><p>Shares of the company were up more than 1% in premarket activity Tuesday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2627413414","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2627413414","pubTimestamp":1776172189,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Amneal Pharmaceuticals  said Tuesday it launched albuterol sulfate and beclomethasone dipropionate inhalation products in the US, following their approval by the Food and Drug Administration in 2025.The company said albuterol sulfate and beclomethasone dipropionate inhalation aerosol products are the generic versions of ProAir HFA and QVAR, respectively, and their launching marks the company's entry into the metered-dose inhaler category.Both inhalers use a hand-breath actuator device, offering an option that had previously been discontinued for QVAR, potentially expanding patient choice, Amneal said.Shares of the company were up more than 1% in premarket activity Tuesday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","AMRX":"Amneal Pharmaceuticals, Inc."},"translate_title":"Amneal Pharmaceuticals在美国推出首批2款吸入器","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMRX":1},"content_text":"Amneal Pharmaceuticals (AMRX) said Tuesday it launched albuterol sulfate and beclomethasone dipropionate inhalation products in the US, following their approval by the Food and Drug Administration in 2025.The company said albuterol sulfate and beclomethasone dipropionate inhalation aerosol products are the generic versions of ProAir HFA and QVAR, respectively, and their launching marks the company's entry into the metered-dose inhaler category.Both inhalers use a hand-breath actuator device, offering an option that had previously been discontinued for QVAR, potentially expanding patient choice, Amneal said.Shares of the company were up more than 1% in premarket activity Tuesday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2627413414","isCrawlerRequest":true}